Hint mode is switched on Switch off

Praxis Precision Medicines, ordinary share
PRAX, US74006W1080

Add a stock to WL
Choose all Reset all
Praxis Precision Medicines, сountry — USA
29/11/2023 stock stopped trading due to affiliation to Praxis Precision Medicines, ordinary share
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    Praxis Precision Medicines Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    PRAX
  • Placement
    16.10.2020
  • Lock up period
    180
  • Number of papers
    10,000,000
  • Volume of raised funds
    190 mln USD
  • Placement share
    27.21%
  • Final placement price
    19 USD
  • Price change since placement date
    -100%
  • By capitalization
    698.24 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    PRAX
  • Placement
    14.05.2021
  • Lock up period
    180
  • Number of papers
    5,000,000
  • Volume of raised funds
    91.25 mln USD
  • Placement share
    11.46%
  • Final placement price
    18.25 USD
  • Price change since placement date
    -100%
  • By capitalization
    796.08 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    PRAX
  • Placement
    29.03.2024
  • Lock up period
    180
  • Number of papers
    3,318,585
  • Volume of raised funds
    187.5 mln USD
  • Placement share
    20.04%
  • Final placement price
    56.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    935.47 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
III q eng
IV q eng
Show all Hide

Indicators

News

29/06/2026 Praxis Precision Medicines: Changes In Registrant's Certifying Accountant, Financial Statements And Exhibits
03/06/2026 Biotech and Tech Stocks Plummet: Abivax S.A. (NASDAQ: ABVX) Leads Market Declines
02/06/2026 Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Target Lowered After Drug Study Setback
07/05/2026 Praxis Precision Medicines: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
06/02/2026 Praxis Precision Medicines: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.